Browse Category

Cryptocurrency News 3 February 2026 - 4 February 2026

Bitcoin price today: BTC slips near $76,000 as ETF outflows return and Fed uncertainty bites

Bitcoin price today: BTC slips near $76,000 as ETF outflows return and Fed uncertainty bites

Bitcoin fell nearly 3% to $75,782 in early New York trading Wednesday, after swinging between $72,971 and $78,345 in the past day. U.S. spot bitcoin ETFs posted $272 million in net outflows Tuesday, reversing Monday’s $561.8 million inflow, according to Farside Investors. Leveraged liquidations reached $2.56 billion as crypto and other risk assets dropped.
Elon Musk’s xAI offers up to $100/hour for crypto experts after SpaceX mega-merger

Elon Musk’s xAI offers up to $100/hour for crypto experts after SpaceX mega-merger

xAI is hiring a remote “Finance Expert – Crypto” to help train its AI models, offering U.S. pay of $45–$100 an hour. The move follows SpaceX’s $1.25 trillion acquisition of xAI, announced by Elon Musk days earlier. xAI’s careers page lists 294 open roles, including several in finance. The crypto job excludes applicants from Wyoming and Illinois and does not offer benefits for part-time hires.
Coinbase (COIN) stock slides as bitcoin sinks — what to watch before earnings

Coinbase (COIN) stock slides as bitcoin sinks — what to watch before earnings

Coinbase shares fell 4.3% to $179.66 Tuesday, tracking a 2.8% drop in bitcoin as forced liquidations erased $2.56 billion in leveraged positions. Crypto and tech stocks slid broadly, with the S&P 500 and Nasdaq also down. U.S. crypto market structure talks remain stalled after a White House meeting. Coinbase resolved minor technical issues on its Kava network.
Strategy Inc (MSTR) stock drops after hours as bitcoin slides; SEC filing shows fresh buy

Strategy Inc (MSTR) stock drops after hours as bitcoin slides; SEC filing shows fresh buy

Strategy Inc shares fell 4.6% after hours to $133.26 as bitcoin slid 3.5% to around $75,772. An SEC filing showed $106.1 million raised from ATM share sales, used to buy 855 bitcoin. The company raised its preferred dividend rate to 11.25% and declared a Feb. 28 payout. Investors await fourth-quarter results on Feb. 5 for updates on funding and dividend plans.
BMNR stock slips as BitMine’s $10.7 billion crypto stash keeps its ether bet in focus

BMNR stock slips as BitMine’s $10.7 billion crypto stash keeps its ether bet in focus

BitMine Immersion Technologies shares fell 3.1% to $22.09 Tuesday, tracking a 1% drop in ether to $2,293. The company disclosed holdings of 4.29 million ETH and $10.7 billion in crypto, cash, and investments as of Feb. 1. BitMine bought 41,788 ETH last week and stakes about 2.9 million ETH. Its MAVAN validator network remains on track for a Q1 2026 launch.
Robinhood stock sinks nearly 10% as Bitcoin slides below $80,000 ahead of Feb. 10 earnings

Robinhood stock sinks nearly 10% as Bitcoin slides below $80,000 ahead of Feb. 10 earnings

Robinhood shares fell 9.62% to $89.91 Monday as bitcoin slumped and trading volume surged to 59 million shares, 136% above average. The drop comes a week before Robinhood’s quarterly earnings report, set for Feb. 10. U.S. stocks closed higher, with the Dow up 1.1%. Coinbase declined for a tenth straight session despite bitcoin rebounding from weekend lows.
Bitcoin slips under Strategy’s break-even, pushing MSTR toward an eighth straight monthly drop

Bitcoin slips under Strategy’s break-even, pushing MSTR toward an eighth straight monthly drop

Strategy sold 673,527 shares for $106.1 million and bought 855 bitcoin last week, raising its holdings to 713,502 coins. The company increased its STRC preferred dividend to 11.25% and set a February payout. Shares fell 6.7% as bitcoin’s drop pushed holdings near break-even and sparked concerns about further purchases. Crypto stocks lagged the market, with $2.56 billion in bitcoin positions liquidated.
Bitcoin breaks below $75,000 as forced selling piles into crypto slide

Bitcoin breaks below $75,000 as forced selling piles into crypto slide

Bitcoin fell to around $74,600 in early Asian trading Wednesday, down 4.8% for the day, as $2.56 billion in positions were liquidated over several days, according to CoinGlass. Analysts cited risk-off sentiment and thin liquidity. Technical signals pointed to further downside, with some traders warning of a drop below $50,000. Shares of Coinbase and Robinhood also moved with the crypto market swings.
Bitcoin’s $79K Bounce Meets $50K Talk as Cathie Wood’s Ark Goes Shopping

Bitcoin’s $79K Bounce Meets $50K Talk as Cathie Wood’s Ark Goes Shopping

Ark Invest increased holdings in crypto-linked stocks, including Circle, Bullish, and BitMine, as bitcoin surged past $79,000 before falling back to around $73,000. Circle shares dropped 7.9% Monday, Coinbase fell 3.5%. Analysts warn bitcoin could slide to $50,000, with bearish sentiment rising. Morgan Stanley began coverage of Circle with an Equal-Weight rating.
Bitcoin Price Slides to Post‑Election Low Near $74,000 as Trump Fed Pick Spurs Fresh Crypto Jitters

Bitcoin Price Slides to Post‑Election Low Near $74,000 as Trump Fed Pick Spurs Fresh Crypto Jitters

Bitcoin fell below $74,425 on Monday, hitting its lowest level since Trump’s return to the White House and extending a nearly four-month slide. The token was down about 5.6% on the day and 15% for the year, after weekend liquidations topped $2.5 billion. Traders cited concerns over Trump’s Fed chair pick and stalled U.S. crypto legislation. Some analysts warned of further downside, with targets as low as $40,000.
Strategy (MSTR) stock price slips with Bitcoin ahead of Feb. 5 earnings

Strategy (MSTR) stock price slips with Bitcoin ahead of Feb. 5 earnings

Strategy Inc shares fell 2.5% to $136.10 by late morning Tuesday as Bitcoin dropped 3% to near $76,700. A new SEC filing showed Strategy bought 855 bitcoins last week for $75.3 million, funded by selling $106 million in stock. The company now holds 713,502 bitcoins at an average price of $76,052. Investors await Strategy’s earnings report after markets close Thursday.
Robinhood (HOOD) stock slips again as bitcoin stays weak; UK ISA rollout and earnings next week in focus

Robinhood (HOOD) stock slips again as bitcoin stays weak; UK ISA rollout and earnings next week in focus

Robinhood shares fell 1.2% to $88.87 Tuesday as crypto-linked stocks tracked bitcoin’s 1.1% drop. The company launched a tax-sheltered stocks & shares ISA in the UK, offering a 2% cash bonus and access to 5,000 U.S.-listed stocks. Investors await Robinhood’s Feb. 10 earnings for signs of trading volume trends and new products. Prediction-market activity faces uncertainty after the U.S. football season ends.
1 3 4 5 6 7 83

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop